Article

Lenstec sales office opens in Barcelona

St. Petersburg, FL-Lenstec Inc. opened a new Barcelona sales office to help the company meet growing European demand for its lens implants and devices used in cataract and refractive surgery. With a sales and marketing office in Yorkshire, England, this move expands Lenstec's European operations.

St. Petersburg, FL-Lenstec Inc. opened a new Barcelona sales office to help the company meet growing European demand for its lens implants and devices used in cataract and refractive surgery. With a sales and marketing office in Yorkshire, England, this move expands Lenstec's European operations.

The new office will serve France, Portugal, and Spain. The company said the Spanish market accounts for one of Europe's highest volumes of refractive surgery procedures.

"Lenstec Spain will advance our global strategy by enabling us to sell products directly to surgeons in these high-growth regions," said John Clough, Lenstec chief executive officer and chairman. "Our goal is to make new technologies such as the Tetraflex accommodating IOL and Softec aberration-controlled cataract lenses readily available across key markets in Europe, Southeast Asia, and the Americas."

Related Videos
Arun Gulani, MD: How the Gni instrument enhances precision and control in cataract surgery
EyeCon 2024: Peter J. McDonnell, MD, marvels on mentoring, modern technology, and ophthalmology’s future
EyeCon Co-chair Oluwatosin U. Smith, MD: Passion for Research and Education Drives Her Commitment to Ophthalmology
Dr. SriniVas Sadda Discusses Vision for ARVO as New President: Collaboration, Funding Challenges, and Impact of Annual Meetings
Highlights from the 18th Annual Controversies in Modern Eye Care Symposium: Arjan Hura, MD, on Refractive Surgery, Retina Care, and Record Attendance
ASCRS 2024: ViaLase Updates on Nonincisional Glaucoma Treatment Targeting Trabecular Meshwork
Dr. Neda Nikpoor Shares Practical Techniques to Combat Unconscious Gender Bias and Promote Gender Equality in Ophthalmology
ASCRS 2024: George O. Waring, MD, shares early clinical performance of bilateral Odyssey implantation
ASCRS 2024: Deborah Gess Ristvedt, DO, discusses third-generation trabecular micro-bypass
© 2024 MJH Life Sciences

All rights reserved.